Search PubMed⌕ Search

PubMed · 12280458

Beyond smallpox eradication.

Abstract

This paper highlights 2 important, under-recognized lessons of the Smallpox Eradication Program (SEP). The 1st lesson is that the discipline and enthusiasm of that vertical campaign could be applied to an attack on several high priority diseases or conditions simultaneously, to great advantage. The 2nd lesson is that eradication of selected diseases remains a uniquely useful tool for advancing the public's health.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D R Hopkins. 1985. Beyond smallpox eradication.. https://pubmed.ncbi.nlm.nih.gov/12280458/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The global impact of drug resistance.

Measuring the impact of drug resistance is an important step in understanding the scope of the problem and formulating policies to limit the emergence and spread of resistant organisms. Studies have focused on measuring the increased costs, morbidity, and mortality in patients with infections due to resistant versus susceptible organisms. These have generally found that resistance worsens outcomes. By focusing only on infected patients, however, they may understate the impact of resistance. It is important to recognize that resistance also affects the treatment of individuals with nonresistant organisms. In areas with high rates of resistance, physicians and governments have changed empiric therapy for malaria, tuberculosis, acute respiratory infections, and other diseases, increasing overall treatment costs. In some instances, these costs may exceed those attributable to treatment failure.

Communicable Diseases↗